Showing results (961-970 of 970) with videos related to
Sort By:
Pageof 97
You have reached the last page of results.This site can display upto 970 results.
Nature Cell Biology|August 6, 2021
ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resectionFei Zhao, Wootae Kim, Huanyao Gao, et al.Cell Reports|February 20, 2026
Clec16a maintains definitive hematopoietic stem and progenitor cells via mitophagyShuyang Cai, Qian Zhang, Qian Luo, et al.Biomedical and Environmental Sciences : BES|January 4, 2022
Kinetic Characteristics of Neutralizing Antibody Responses Vary among Patients with COVID-19Ling Hua Li, Hong Wei Tu, Dan Liang, et al.BMC Plant Biology|August 13, 2021
OrchidBase 4.0: a database for orchid genomics and molecular biologyYu-Yun Hsiao, Chih-Hsiung Fu, Sau-Yee Ho, et al.Molecular Cell|June 27, 2025
Isoform-specific function of NSD3 in DNA replication stress confers resistance to PARP inhibitors in prostate cancerShouhai Zhu, Huanyao Gao, Dan Jiang, et al.ACS Central Science|February 27, 2023
Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLproNingke Hou, Lei Shuai, Lijing Zhang, et al.Chinese Journal of Integrative Medicine|January 5, 2026
Andrographolide Sulfonate Injection for Adjunctive Treatment of Non-severe Community-Acquired Pneumonia in Adults: A Multicenter, Double-Blind, Randomized Controlled TrialLian-Han Shang, Guo-Hui Fan, Li-Ping Chen, et al.Journal of Thrombosis and Haemostasis : JTH|November 25, 2021
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension studyHeng Mei, Xiaofan Liu, Yan Li, et al.Journal of Hematology & Oncology|February 26, 2021
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopeniaHeng Mei, Xiaofan Liu, Yan Li, et al.Hepatology International|April 14, 2017
CSH guidelines for the diagnosis and treatment of drug-induced liver injuryYue-Cheng Yu, Yi-Min Mao, Cheng-Wei Chen, et al.Pageof 97